Cancer
-
Dr. Reddy’s expands access to immunotherapy for rare nasopharyngeal cancer in South Africa
The U.S. National Cancer Institute estimates that more than 500 rare cancers exist, many of which receive limited public attention despite their significant impact on patients and families.
-
Mayo Clinic study uncovers mechanism behind resistance to HER2 breast cancer drug
The researchers say the finding could help guide the development of more targeted treatment combinations for patients whose tumors produce the protein.
-
Labcorp expands precision oncology portfolio with FDA clearance for melanoma test
The approval allows the company’s PGDx elio tissue complete CDx to be used in hospitals and clinical laboratories across the United States to help identify patients who may benefit from targeted treatment.
-
BeOne Medicines collaborates with Revolution Medicines on RAS-targeted cancer treatments
The agreement covers joint clinical studies that will combine BeOne’s oncology pipeline with four clinical-stage RAS(ON) inhibitors developed by Revolution Medicines: daraxonrasib, zoldonrasib, elironrasib and RMC-5127.
-
Jazz Pharmaceuticals to withdraw Zepzelca’s second-line SCLC indication after failed trial
The decision follows the failure of the phase 3 Lagoon trial, which did not meet its primary endpoint of overall survival.
-
Median Technologies collaborates with Olea Medical to commercialize AI lung cancer software
eyonis LCS is a Software as a Medical Device that uses AI to assist clinicians in detecting and diagnosing lung cancer during screening workflows.
-
GSK secures first lung cancer approval days after US$10.6B Nuvalent acquisition
The US Food and Drug Administration (FDA) approved Jideytro for adults with locally advanced or metastatic ROS1-positive NSCLC who have previously received treatment with a ROS1 kinase inhibitor.
-
Kenya records 35,867 new cancer cases in latest GLOBOCAN 2024 estimates
Breast cancer remains the country’s most commonly diagnosed cancer, accounting for 5,822 new cases, or 16.2% of all cancers.
-
GE HealthCare leverages MIM software to advance personalized oncology with Mayo Clinic
Researchers will use GE HealthCare’s StarGuide SPECT/CT imaging system together with MIM Software’s MIM LesionID Pro platform to monitor how tumours respond throughout treatment.
-
Kenyatta National Hospital launches minimally invasive esophageal surgery protocol in Nairobi
Unlike conventional open surgery, which requires large incisions in the chest and abdomen, MIE uses several small incisions, high-definition imaging, and specialized laparoscopic instruments.